<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="editorial"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">EXCLI J</journal-id><journal-id journal-id-type="iso-abbrev">EXCLI J</journal-id><journal-id journal-id-type="publisher-id">EXCLI J</journal-id><journal-title-group><journal-title>EXCLI Journal</journal-title></journal-title-group><issn pub-type="epub">1611-2156</issn><publisher><publisher-name>Leibniz Research Centre for Working Environment and Human Factors</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31938029</article-id><article-id pub-id-type="pmc">6953534</article-id><article-id pub-id-type="publisher-id">2019-2072</article-id><article-id pub-id-type="doi">10.17179/excli2019-2072</article-id><article-id pub-id-type="publisher-id">Doc1099</article-id><article-categories><subj-group subj-group-type="heading"><subject>Editorial Material</subject></subj-group></article-categories><title-group><article-title>Tumor suppressor role of genes involved in circadian clock control</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hassan</surname><given-names>Reham</given-names></name><xref ref-type="corresp" rid="COR1">*</xref><xref ref-type="aff" rid="A1">1</xref></contrib></contrib-group><aff id="A1">
<label>1</label>Forensic Medicine and Toxicology Department, Faculty of Veterinary Medicine, South Valley University, Qena, Egypt</aff><author-notes><corresp id="COR1">*To whom correspondence should be addressed: Reham Hassan, Forensic Medicine and Toxicology Department, Faculty of Veterinary Medicine, South Valley University, Qena, Egypt, E-mail: <email>reham_hassan@vet.svu.edu.eg</email></corresp></author-notes><pub-date pub-type="epub"><day>19</day><month>12</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>18</volume><fpage>1099</fpage><lpage>1100</lpage><history><date date-type="received"><day>16</day><month>12</month><year>2019</year></date><date date-type="accepted"><day>17</day><month>12</month><year>2019</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2019 Hassan</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>) You are free to copy, distribute and transmit the work, provided the original author and source are credited.</license-p></license></permissions><self-uri xlink:type="simple" xlink:href="https://www.excli.de/vol18/Hassan_19122019_proof.pdf">This article is available from https://www.excli.de/vol18/Hassan_19122019_proof.pdf</self-uri></article-meta></front><body><sec><title>&#x0206f;&#x0206f;&#x0206f;&#x0206f;&#x0206f;</title><p>In recent years evidence has accumulated that genes involved in circadian clock control play a role as tumor suppressors. Strong evidence has been presented by Broadberry and colleagues who published an article about disrupted circadian clocks in breast cancer (Broadberry et al., 2018[<xref rid="R1" ref-type="bibr">1</xref>]). The authors studied primary mammary epithelial cells from normal breast tissue and epithelial cells from breast carcinomas of the same patients. They transduced the cells with the luciferase clock reporter PER2:Luc, which is known to show a robust ~24 h rhythm in normal epithelial cells (Yang et al., 2017[<xref rid="R20" ref-type="bibr">20</xref>]). The normal epithelial breast cells showed the expected cycling. However, epithelial cells from the cancer tissue of the same individuals showed a disrupted rhythm with a much lower amplitude (Broadberry et al., 2018[<xref rid="R1" ref-type="bibr">1</xref>]). This study confirms previous studies presenting evidence for a tumor suppressor role of the circadian clock (Gery and Koeffler, 2010[<xref rid="R7" ref-type="bibr">7</xref>]; Grundy et al., 2013[<xref rid="R9" ref-type="bibr">9</xref>]; Fu and Lee, 2003[<xref rid="R6" ref-type="bibr">6</xref>]; Mormont and L&#x000e9;vi, 1997[<xref rid="R15" ref-type="bibr">15</xref>]; Filipski et al., 2002[<xref rid="R5" ref-type="bibr">5</xref>]). Loss of clock genes has been shown to be associated with worse prognosis in breast cancer (Cadenas et al., 2014[<xref rid="R3" ref-type="bibr">3</xref>]). Coordinated co-expression of clock genes (e.g. PER2-PER3 and CRY2-PER3) is maintained in estrogen receptor positive and HER2 negative carcinomas but is compromised in more aggressive tumors (Cadenas et al., 2014[<xref rid="R3" ref-type="bibr">3</xref>]). Genes relevant for progression of breast carcinomas have been shown to be associated with proliferation (Siggelkow et al., 2012[<xref rid="R18" ref-type="bibr">18</xref>]), the cellular and humoral immune system (Schmidt et al., 2008[<xref rid="R16" ref-type="bibr">16</xref>], 2012[<xref rid="R17" ref-type="bibr">17</xref>]; Heimes et al., 2017[<xref rid="R10" ref-type="bibr">10</xref>][<xref rid="R11" ref-type="bibr">11</xref>]; Lohr et al., 2013[<xref rid="R13" ref-type="bibr">13</xref>]; Godoy et al., 2014[<xref rid="R8" ref-type="bibr">8</xref>]), anti-oxidative and anti-apoptotic factors (Hellwig et al., 2016[<xref rid="R12" ref-type="bibr">12</xref>]; Cadenas et al., 2010[<xref rid="R2" ref-type="bibr">2</xref>]) and altered metabolism (Cadenas et al., 2019[<xref rid="R4" ref-type="bibr">4</xref>]; Marchan et al., 2017[<xref rid="R14" ref-type="bibr">14</xref>]; Stewart et al., 2012[<xref rid="R19" ref-type="bibr">19</xref>]). Although the loss of circadian clock gene expression and its association with tumor prognosis has clearly been shown, the mechanisms of their tumor suppressive effect still need to be elucidated. </p></sec></body><back><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal">
<person-group><name><surname>Broadberry</surname><given-names>E</given-names></name><name><surname>McConnell</surname><given-names>J</given-names></name><name><surname>Williams</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>N</given-names></name><name><surname>Zindy</surname><given-names>E</given-names></name><name><surname>Leek</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Disrupted circadian clocks and altered tissue mechanics in primary human breast tumours</article-title>
<source>Breast Cancer Res</source>
<year>2018</year>
<volume>20</volume>
<fpage>125</fpage>
<pub-id pub-id-type="pmid">30348208</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal">
<person-group><name><surname>Cadenas</surname><given-names>C</given-names></name><name><surname>Franckenstein</surname><given-names>D</given-names></name><name><surname>Schmidt</surname><given-names>M</given-names></name><name><surname>Gehrmann</surname><given-names>M</given-names></name><name><surname>Hermes</surname><given-names>M</given-names></name><name><surname>Geppert</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer</article-title>
<source>Breast Cancer Res</source>
<year>2010</year>
<volume>12</volume>
<issue>3</issue>
<fpage>R44</fpage>
<pub-id pub-id-type="pmid">20584310</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal">
<person-group><name><surname>Cadenas</surname><given-names>C</given-names></name><name><surname>van de Sandt</surname><given-names>L</given-names></name><name><surname>Edlund</surname><given-names>K</given-names></name><name><surname>Lohr</surname><given-names>M</given-names></name><name><surname>Hellwig</surname><given-names>B</given-names></name><name><surname>Marchan</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Loss of circadian clock gene expression is associated with tumor progression in breast cancer</article-title>
<source>Cell Cycle</source>
<year>2014</year>
<volume>13</volume>
<fpage>3282</fpage>
<lpage>3291</lpage>
<pub-id pub-id-type="pmid">25485508</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal">
<person-group><name><surname>Cadenas</surname><given-names>C</given-names></name><name><surname>Vosbeck</surname><given-names>S</given-names></name><name><surname>Edlund</surname><given-names>K</given-names></name><name><surname>Grgas</surname><given-names>K</given-names></name><name><surname>Madjar</surname><given-names>K</given-names></name><name><surname>Hellwig</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>LIPG-promoted lipid storage mediates adaptation to oxidative stress in breast cancer</article-title>
<source>Int J Cancer</source>
<year>2019</year>
<volume>145</volume>
<fpage>901</fpage>
<lpage>915</lpage>
<pub-id pub-id-type="pmid">30653260</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal">
<person-group><name><surname>Filipski</surname><given-names>E</given-names></name><name><surname>King</surname><given-names>VM</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Granda</surname><given-names>TG</given-names></name><name><surname>Mormont</surname><given-names>MC</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><etal/></person-group>
<article-title>Host circadian clock as a control point in tumor progression</article-title>
<source>J Natl Cancer Inst</source>
<year>2002</year>
<volume>94</volume>
<fpage>690</fpage>
<lpage>697</lpage>
<pub-id pub-id-type="pmid">11983758</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal">
<person-group><name><surname>Fu</surname><given-names>L</given-names></name><name><surname>Lee</surname><given-names>CC</given-names></name></person-group>
<article-title>The circadian clock: pacemaker and tumour suppressor</article-title>
<source>Nat Rev Cancer</source>
<year>2003</year>
<volume>3</volume>
<fpage>350</fpage>
<lpage>361</lpage>
<pub-id pub-id-type="pmid">12724733</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal">
<person-group><name><surname>Gery</surname><given-names>S</given-names></name><name><surname>Koeffler</surname><given-names>HP</given-names></name></person-group>
<article-title>Circadian rhythms and cancer</article-title>
<source>Cell Cycle</source>
<year>2010</year>
<volume>9</volume>
<fpage>1097&#x02013;103</fpage>
<pub-id pub-id-type="pmid">20237421</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal">
<person-group><name><surname>Godoy</surname><given-names>P</given-names></name><name><surname>Cadenas</surname><given-names>C</given-names></name><name><surname>Hellwig</surname><given-names>B</given-names></name><name><surname>Marchan</surname><given-names>R</given-names></name><name><surname>Stewart</surname><given-names>J</given-names></name><name><surname>Reif</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response</article-title>
<source>Breast Cancer</source>
<year>2014</year>
<volume>21</volume>
<fpage>491</fpage>
<lpage>499</lpage>
<pub-id pub-id-type="pmid">23001506</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal">
<person-group><name><surname>Grundy</surname><given-names>A</given-names></name><name><surname>Schuetz</surname><given-names>JM</given-names></name><name><surname>Lai</surname><given-names>AS</given-names></name><name><surname>Janoo-Gilani</surname><given-names>R</given-names></name><name><surname>Leach</surname><given-names>S</given-names></name><name><surname>Burstyn</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>Shift work, circadian gene variants and risk of breast cancer</article-title>
<source>Cancer Epidemiol</source>
<year>2013</year>
<volume>37</volume>
<fpage>606</fpage>
<lpage>612</lpage>
<pub-id pub-id-type="pmid">23725643</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal">
<person-group><name><surname>Heimes</surname><given-names>AS</given-names></name><name><surname>Madjar</surname><given-names>K</given-names></name><name><surname>Edlund</surname><given-names>K</given-names></name><name><surname>Battista</surname><given-names>MJ</given-names></name><name><surname>Almstedt</surname><given-names>K</given-names></name><name><surname>Elger</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Subtype-specific prognostic impact of different immune signatures in node-negative breast cancer</article-title>
<source>Breast Cancer Res Treat</source>
<year>2017</year>
<volume>165</volume>
<fpage>293</fpage>
<lpage>300</lpage>
<pub-id pub-id-type="pmid">28585074</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal">
<person-group><name><surname>Heimes</surname><given-names>AS</given-names></name><name><surname>Madjar</surname><given-names>K</given-names></name><name><surname>Edlund</surname><given-names>K</given-names></name><name><surname>Battista</surname><given-names>MJ</given-names></name><name><surname>Almstedt</surname><given-names>K</given-names></name><name><surname>Gebhard</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer</article-title>
<source>J Cancer Res Clin Oncol</source>
<year>2017</year>
<volume>143</volume>
<fpage>1123</fpage>
<lpage>1131</lpage>
<pub-id pub-id-type="pmid">28251349</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal">
<person-group><name><surname>Hellwig</surname><given-names>B</given-names></name><name><surname>Madjar</surname><given-names>K</given-names></name><name><surname>Edlund</surname><given-names>K</given-names></name><name><surname>Marchan</surname><given-names>R</given-names></name><name><surname>Cadenas</surname><given-names>C</given-names></name><name><surname>Heimes</surname><given-names>AS</given-names></name><etal/></person-group>
<article-title>Epsin family member 3 and ribosome-related genes are associated with late metastasis in estrogen receptor-positive breast cancer and long-term survival in non-small cell lung cancer using a genome-wide identification and validation strategy</article-title>
<source>PLoS One</source>
<year>2016</year>
<volume>11</volume>
<issue>12</issue>
<fpage>e0167585</fpage>
<pub-id pub-id-type="pmid">27926932</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal">
<person-group><name><surname>Lohr</surname><given-names>M</given-names></name><name><surname>Edlund</surname><given-names>K</given-names></name><name><surname>Botling</surname><given-names>J</given-names></name><name><surname>Hammad</surname><given-names>S</given-names></name><name><surname>Hellwig</surname><given-names>B</given-names></name><name><surname>Othman</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer</article-title>
<source>Cancer Lett</source>
<year>2013</year>
<volume>333</volume>
<fpage>222</fpage>
<lpage>228</lpage>
<pub-id pub-id-type="pmid">23370224</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal">
<person-group><name><surname>Marchan</surname><given-names>R</given-names></name><name><surname>B&#x000fc;ttner</surname><given-names>B</given-names></name><name><surname>Lambert</surname><given-names>J</given-names></name><name><surname>Edlund</surname><given-names>K</given-names></name><name><surname>Glaeser</surname><given-names>I</given-names></name><name><surname>Blaszkewicz</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Glycerol-3-phosphate acyltransferase 1 promotes tumor cell migration and poor survival in ovarian carcinoma</article-title>
<source>Cancer Res</source>
<year>2017</year>
<volume>77</volume>
<fpage>4589</fpage>
<lpage>4601</lpage>
<pub-id pub-id-type="pmid">28652252</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal">
<person-group><name><surname>Mormont</surname><given-names>MC</given-names></name><name><surname>L&#x000e9;vi</surname><given-names>F</given-names></name></person-group>
<article-title>Circadian-system alterations during cancer processes: a review</article-title>
<source>Int J Cancer</source>
<year>1997</year>
<volume>70</volume>
<fpage>241</fpage>
<lpage>247</lpage>
<pub-id pub-id-type="pmid">9009166</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal">
<person-group><name><surname>Schmidt</surname><given-names>M</given-names></name><name><surname>B&#x000f6;hm</surname><given-names>D</given-names></name><name><surname>von T&#x000f6;rne</surname><given-names>C</given-names></name><name><surname>Steiner</surname><given-names>E</given-names></name><name><surname>Puhl</surname><given-names>A</given-names></name><name><surname>Pilch</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>The humoral immune system has a key prognostic impact in node-negative breast cancer</article-title>
<source>Cancer Res</source>
<year>2008</year>
<volume>68</volume>
<fpage>5405</fpage>
<lpage>5413</lpage>
<pub-id pub-id-type="pmid">18593943</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal">
<person-group><name><surname>Schmidt</surname><given-names>M</given-names></name><name><surname>Hellwig</surname><given-names>B</given-names></name><name><surname>Hammad</surname><given-names>S</given-names></name><name><surname>Othman</surname><given-names>A</given-names></name><name><surname>Lohr</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><etal/></person-group>
<article-title>A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin &#x003ba; C as a compatible prognostic marker in human solid tumors</article-title>
<source>Clin Cancer Res</source>
<year>2012</year>
<volume>18</volume>
<fpage>2695</fpage>
<lpage>2703</lpage>
<pub-id pub-id-type="pmid">22351685</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal">
<person-group><name><surname>Siggelkow</surname><given-names>W</given-names></name><name><surname>Boehm</surname><given-names>D</given-names></name><name><surname>Gebhard</surname><given-names>S</given-names></name><name><surname>Battista</surname><given-names>M</given-names></name><name><surname>Sicking</surname><given-names>I</given-names></name><name><surname>Lebrecht</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Expression of aurora kinase A is associated with metastasis-free survival in node-negative breast cancer patients</article-title>
<source>BMC Cancer</source>
<year>2012</year>
<volume>12</volume>
<fpage>562</fpage>
<pub-id pub-id-type="pmid">23186136</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal">
<person-group><name><surname>Stewart</surname><given-names>JD</given-names></name><name><surname>Marchan</surname><given-names>R</given-names></name><name><surname>Lesjak</surname><given-names>MS</given-names></name><name><surname>Lambert</surname><given-names>J</given-names></name><name><surname>Hergenroeder</surname><given-names>R</given-names></name><name><surname>Ellis</surname><given-names>JK</given-names></name><etal/></person-group>
<article-title>Choline-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasis</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2012</year>
<volume>109</volume>
<fpage>8155</fpage>
<lpage>8160</lpage>
<pub-id pub-id-type="pmid">22570503</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal">
<person-group><name><surname>Yang</surname><given-names>N</given-names></name><name><surname>Williams</surname><given-names>J</given-names></name><name><surname>Pekovic-Vaughan</surname><given-names>V</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Olabi</surname><given-names>S</given-names></name><name><surname>McConnell</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Cellular mechano-environment regulates the mammary circadian clock. Nat</article-title>
<source>Comm</source>
<year>2017</year>
<volume>8</volume>
<fpage>14287</fpage>
</element-citation></ref></ref-list></back></article>